Phase 2 Study of Sorafenib, Valproic Acid, and Sildenafil in the Treatment of Recurrent High-Grade GliomaAndrew S Poklepovic(Virginia Commonwealth University), Mark G. Malkin(Cleveland Clinic)medRxivApril 24, 202410.1101/2024.04.23.24304634Cited by 4SaveCiteExport RISWatch citationsRelated PapersSuperiority of PCNU over AZQ in the treatment of primary brain tumors: results of a prospective randomized trial (81-20) by the brain tumor study group|Journal of Neuro-Oncology|1994|9